Registered Starting Material (RSM) Pharma Service – Regulatory-Compliant, Risk-Controlled, and Scalable Supply

As a Manufacturer & Solution Provider, Lianhe Aigen delivers integrated Registered Starting Material (RSM) Pharma Services to support global pharmaceutical companies from preclinical development to commercial API supply.

Why RSM Pharma Service Matters

Registered Starting Materials (RSMs) are critical intermediates in API development, forming the foundation for regulatory-compliant drug substances. Proper RSM management ensures consistent quality, traceability, and risk-controlled manufacturing across all stages of drug development.

Lianhe Aigen provides comprehensive RSM Pharma Services, covering preclinical RSM supply, clinical-stage RSM manufacturing, and commercial-scale RSM production. As a trusted Manufacturer & Solution Provider, we enable seamless integration from RSM development to Drug Substance CDMO projects, supporting global regulatory compliance and project timelines.

Our Registered Starting Material (RSM) Capabilities

Lianhe Aigen’s RSM Pharma Service ensures technical and operational excellence at every stage:

• Preclinical RSM supply: supporting early-stage drug discovery and IND-enabling research

• Clinical-stage RSM manufacturing: scalable and controlled processes for clinical development

• Commercial-scale RSM production: reliable, compliant supply for commercial APIs

• Process development & optimization: reproducible, risk-controlled manufacturing

• Integrated CRDMO capabilities: seamless transition from RSM to Drug Substance and commercial manufacturing

Key features:

Regulatory-Compliant RSM Production: Meeting global quality and safety standards.

Custom Synthesis: Tailored RSM solutions for specific drug processes.

Scalable Manufacturing: Flexible production capabilities for varying project needs.

Quality Assurance: Rigorous testing and documentation for regulatory approval.

We provide dependable RSM solutions that align with your pharmaceutical objectives.

Quality & Regulatory Compliance

Quality and compliance are central to our Registered Starting Material (RSM) Pharma Service:

• Fully compliant with GxP regulations and ICH Q7 guidelines

• Facilities successfully inspected by FDA, EMA, PMDA, TGA, KFDA, NMPA

• Complete traceability of raw materials and intermediates

• Robust change control and deviation management systems

• Support for customer audits and regulatory filings

Our quality system ensures every RSM batch is risk-controlled, consistent, and ready for regulatory submission, from preclinical research through commercial API supply.

Typical RSM Project Scenarios

Lianhe Aigen delivers high-quality RSMs for a range of project needs:

• Preclinical-stage RSM supply for early drug candidates

• Clinical-stage RSM manufacturing for IND-enabling studies

• Commercial-scale RSM production with long-term supply assurance

• Technology transfer and process scale-up for reproducible production

Why Partner with Lianhe Aigen

As a Manufacturer & Solution Provider, Lianhe Aigen combines:

• End-to-end CRDMO capabilities covering RSM, Drug Substance, and commercial API stages

• Proven track record with FDA, EMA, PMDA, TGA, KFDA, NMPA inspections

• Long-term, risk-controlled RSM supply for global pharmaceutical clients

• Experienced team in process development, quality assurance, and regulatory compliance

Partnering with Lianhe Aigen ensures your RSM supply chain is robust, compliant, and capable of supporting critical projects from preclinical to commercial stages.

Accelerate your drug development with professional Registered Starting Material (RSM) Pharma Services from a trusted Manufacturer & Solution Provider.